Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 8NET 1Endocrine 1

Conditions

Rectal Neuroendocrine Tumors 1

Interventions

Observation 2Interviews as Topic 2Fluorouracil 2Carboplatin 2Adrenalectomy 2zimberelimab 1trametinib 1lutetium Lu 177 dotatate 1dabrafenib 1cemiplimab 1apatinib 1anlotinib 1Watchful Waiting 1Thyroxine 1Surveys and Questionnaires 1Standard of Care 1Radiomics 1Radiation 1Positron Emission Tomography Computed Tomography 1Mitoxantrone 1Leucovorin 1Irinotecan 1Injections 1IFL protocol 1Etoposide 1Engineering 1Endoscopic Mucosal Resection 1Decision Support Techniques 1Counseling 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Endoscopic Mucosal Resection × Endocrine × Clear all
NCT07373015 2026-01-28

Modified Double Snare Assisted EMR (mDS-EMR) VS ESD for Rectal Neuroendocrine Tumors Smaller Than 1cm

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase NA Not yet recruiting
118 enrolled
EndocrineGastrointestinalNET

Rectal Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡